Events
miRagen Therapeutics, Inc. announced that management will be presenting at the Evercore ISI HealthCONx Conference 2019 on Tuesday, December 3rd, taking place at the Four Seasons Hotel in Boston, Massachusetts.
Neoleukin Therapeutics, Inc. “Neoleukin” announced that Jonathan Drachman, M.D., Chief Executive Officer, will present at the Piper Jaffray 31st Annual Healthcare Conference on Thursday, December 5, 2019 at 2:50 p.m. EST in New York.
Krystal Biotech Inc. announced that Krish S. Krishnan, chairman and chief executive officer, will present at the Piper Jaffray 31st Annual Healthcare Conference in New York City being held Dec. 3-5 in New York.
Intellia Therapeutics, Inc., a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will present at the Evercore ISI 2nd Annual HealthCONx Conference on Tuesday, December 3, 2019 at 8:20 a.m. ET in Boston, MA..
Ovid Therapeutics Inc. announced that Amit Rakhit, M.D., President and Chief Medical Officer, will participate in an analyst-led fireside chat at the 31st Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2019, at 4:00 p.m. EST.
Harpoon Therapeutics, Inc. announced that Gerald McMahon, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 31st Annual Piper Jaffray Healthcare Conference.
Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, announced that the company will participate in the following upcoming investor conferences in December
Satsuma Pharmaceuticals, Inc. announced that John Kollins, Satsuma President and Chief Executive Officer, will present a corporate update at the Evercore ISI HealthCONx Investor Conference, taking place December 3-5, 2019 in Boston.
G1 Therapeutics, Inc., a clinical-stage oncology company, announced that Chief Executive Officer Mark Velleca, M.D., Ph.D. will participate in a fireside chat at the Evercore ISI 2nd Annual HealthCONx Conference.
Landos Biopharma announced that Dr. Josep Bassaganya-Riera, Chairman, President and Chief Executive Officer, will present at the following conference in New York.
PRESS RELEASES